医学
经皮冠状动脉介入治疗
内科学
心脏病学
冠状动脉疾病
肾脏疾病
血运重建
心肌梗塞
冠状动脉搭桥手术
透析
动脉
外科
作者
Xin Ren,Wei Liu,Yong Peng,Li Qiao,Hua Chai,Zhengang Zhang,Qingtao Meng,Chi Chen,Chen Zhang,Xin Luo,Mao Chen,Dejia Huang
出处
期刊:Renal Failure
[Informa]
日期:2014-07-02
卷期号:36 (8): 1177-1186
被引量:6
标识
DOI:10.3109/0886022x.2014.934178
摘要
Previous reports of percutaneous coronary intervention versus coronary artery bypass graft outcomes in coronary artery disease patients with chronic kidney disease (CKD) were inconsistent. We evaluated the optimal revascularization strategy for CKD patients. We searched Pub Med, EMBASE, and the Cochrane Central Register of Controlled Trials and scanned the references of relevant articles and reviews. All studies that compared relevant clinical outcomes between percutaneous coronary intervention and coronary artery bypass graft in CKD patients were selected. We defined short-term and long-term all-cause mortality as primary outcome, and long-term incidences of myocardial infarction and revascularization as secondary outcomes. A total of 2235 citations were retrieved, and 31 studies involving 99,054 patients, with 55,383 receiving percutaneous coronary intervention and 43,671 receiving coronary artery bypass graft, were included. In subgroup analyses of dialysis patients receiving percutaneous coronary intervention with stents versus coronary artery bypass graft, CKD patients with multivessel coronary disease, and CKD patients receiving drug-eluting stent versus coronary artery bypass graft, the pooled outcomes revealed that percutaneous coronary intervention possessed lower short-term mortality, but higher late revascularization risk. No significant differences in long-term mortality were observed between the two strategies in these subgroup analyses. In conclusion, in some specific clinical circumstances, CKD patients receiving percutaneous coronary intervention possessed lower short-term all-cause mortality, but higher long-term revascularization risk, than coronary artery bypass graft; long-term all-cause mortality was not different between the two strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI